Raloxifene Hydrochloride News
Raloxifene Hydrochloride currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Raloxifene Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. A significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated....
- Evidence level: L5
- Predicted indications (20):
- duodenal ulcer (disease) (99.7%)
- obsolete susceptibility to ischemic stroke (99.7%)
- hypoalphalipoproteinemia (99.7%)
- duodenal obstruction (99.6%)
- duodenogastric reflux (99.6%)
- postmenopausal osteoporosis (99.1%)
- Worth syndrome (99.0%)
- homozygous familial hypercholesterolemia (98.7%)
- autosomal dominant neovascular inflammatory vitreoretinopathy (98.6%)
- pregnancy associated osteoporosis (98.5%)
- cerebral infarction (98.2%)
- brain stem infarction (98.0%)
- obsolete familial combined hyperlipidemia (98.0%)
- ABri amyloidosis (97.5%)
- amenorrhea (disease) (97.4%)
- succinyl-CoA:3-ketoacid CoA transferase deficiency (97.4%)
- cerebral artery occlusion (97.1%)
- cerebral arterial disease (96.8%)
- acne (disease) (96.3%)
- Prinzmetal angina (95.8%)
Related News (1)
Rivoluzione incretine, i farmaci anti-obesità ora diventano pillole. «Dosaggi saranno più facili da gestire» - Il Messaggero
2026-10-10 tumor ictus obesità
Source: Il Messaggero
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.